SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2015 SESSION
McWaters (Chairman), Lucas, Carrico, Garrett, Barker
Clerk: Patty Lung
Staff: Thomas Stevens, Ryan Brimmer
Date of Meeting: February 17, 2015
Time and Place: Upon Adj. of Health Subcommittee - 3rd Fl. East Conf. Room
H.B. 1733 Prescription drug orders; delivery to PACE program facility.
Patron: Hodges
Delivery of prescription drug orders; PACE programs. Provides that prescription drug orders dispensed to a patient and delivered to a program of all-inclusive care for the elderly (PACE) facility licensed by the Department of Medical Assistance Services may be stored, retained, and repackaged at the facility on behalf of a patient for subsequent delivery or administration The bill requires that repackaging of dispensed prescription drugs retained by the PACE facility be performed by a pharmacist, pharmacy technician, nurse, or other person who has successfully completed a Board-approved training program for such purpose. The bill directs the Board of Pharmacy to promulgate regulations related to training, packaging, labeling, and recordkeeping for such repackaging.
H.B. 1735 Optometrists, TPA-certified; administration of certain Schedule II drugs.
Patron: Hodges
TPA-certified optometrists; administration of certain Schedule II drugs. Allows TPA-certified optometrists to administer Schedule II drugs consisting of hydrocodone in combination with acetaminophen, in accordance with federal law. The bill contains technical amendments.
H.B. 1736 Wholesale distributors; notice to Board of Pharmacy when ceasing distribution of certain drugs.
Patron: Hodges
Wholesale distributors; notice to Board of Pharmacy when ceasing distribution to a dispenser due to suspicious ordering. Requires a wholesale distributor or nonresident wholesale distributor that ceases distribution of Schedule II through V drugs to a pharmacy, licensed physician dispenser, or licensed physician dispensing facility located in the Commonwealth due to suspicious orders of controlled substances to notify the Board of Pharmacy within five days of the cessation. The bill defines "suspicious orders of controlled substances;" provides that a wholesale distributor or nonresident wholesale distributor shall be immune from civil liability for notifying the Board of Pharmacy in accordance with this act unless such notice was given in bad faith or with malicious intent; and provides that the Board of Pharmacy shall not impose any disciplinary or enforcement action against a licensee or permit holder solely on the basis of notice received from a wholesale distributor or nonresident wholesale distributor in accordance with this act.
H.B. 1737 Outsourcing facilities; new regulatory framework created for permitting.
Patron: Hodges
Outsourcing facilities and nonresident outsourcing facilities and compounding for office-based administration. Creates a new regulatory framework for permitting of outsourcing facilities thatcompound drugs and are located within the Commonwealth and registering nonresident outsourcing facilities in the Commonwealth.
H.B. 1738 Hospices; notice to dispenser of patient's death within 48 hours.
Patron: Hodges
Hospices; notice to dispenser of patient's death. Requires every hospice licensed by the Department of Health or exempt from licensure pursuant to § 32.1-162.2 with a hospice patient residing at home at the time of death to notify every pharmacy that has dispensed partial quantities of a Schedule II controlled substance for a patient with a medical diagnosis documenting a terminal illness, as authorized by federal law, within 48 hours of the patient's death.